Uncategorized - February 25, 2015
Could Saunas Reduce Heart Attack Risk?
Men who frequently use saunas had reduced risks of fatal cardiovascular events and mortality from other causes, according to an article published online by JAMA Internal Medicine. Jari A. Laukkanen, M.D., Ph.D., of the University of Eastern Finland, Kuopio, and coauthors investigated the connection between sauna bathing and the risk of SCD, fatal coronary heart disease (CHD), […]
Uncategorized - February 23, 2015
Research Focusing on Parasites
Research conducted in Norway, Estonia, South Africa, the United Kingdom and likely soon Spain is examining the connection between parasitic infections and allergies and asthma. Professor Cecilie Svanes at the Centre for International Health at the University of Bergen (UiB), noted that German researchers have found antibodies suggesting that 10 to 20 percent of people […]
Uncategorized - February 20, 2015
Brain Suffers if Sleep Deprived
Scientists are further researching the idea that brains “cleanse” themselves of waste proteins during sleep and too little sleep could contribute to diseases such as Alzheimer’s, schizophrenia, depression and ADHD. A research team, lead by Professor Maiken Nedergaard from the University of Rochester Medical Center, made a huge breakthrough in sleep research in 2013, when Nedergaard and […]
Uncategorized - February 20, 2015
Uppsala Doctor Receives Grant
A cardiologist at Sweden’s University Hospital and Uppsala Clinical Research Center received a 300 000 kronor grant to study the incidence of spontaneous coronary artery dissection in women with heart attacks and the prognosis for these patients. While spontaneous coronary artery dissection is a rare cause of a heart attack, most of those stricken are young […]
Uncategorized - February 20, 2015
Positive Phase 2 Trial for Oral Insulin
Novo Nordisk has successfully completed the phase 2 trial for OG217SC, an oral formulation of the long-acting GLP-1 analogue semaglutidea, a form of oral insulin, sending its stock shares climbing. Semaglutide appeared to have “a safe and well-tolerated profile,” according to Novo Nordisk. The 26-week trial included tests of dose range, escalation, efficacy and safety of once-daily doses […]
Uncategorized - February 19, 2015
Link Between Type 2 Diabetes, Alzheimer’s
Having type 2 diabetes could increase one’s chances of developing Alzheimer’s Disease, according to a study by researchers at Uppsala University in Sweden. The risk comes from amyloid deposits that characterize Alzheimer’s disease forming in the pancreas of type 2 diabetics. Both diseases are characterized by a process called amyloidosis, in which misfolded proteins accumulate into fibrous […]